Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin's lymphomas at advanced stage: Results of a phase II trial

Cancer Biotherapy and Radiopharmaceuticals

Volumn 16, Issue 2, 2001, Pages 171-177

  Todisco, Mauro ^a   Casaccia, Piergiorgio ^b  

^a Local Health Department of National Health Service   (Italy)

^b Public Health Department of the Local Health Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CORTICOTROPIN; CYCLOPHOSPHAMIDE; MELATONIN; RETINOID; SOMATOSTATIN;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DROWSINESS; FEMALE; HUMAN; HYPERGLYCEMIA; MALE; NONHODGKIN LYMPHOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT INDICATION;

ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; BROMOCRIPTINE; CYCLOPHOSPHAMIDE; DRUG EVALUATION; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MELATONIN; MIDDLE AGED; RETINOIDS; SOMATOSTATIN; TREATMENT OUTCOME;

EID: 0035704804     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/108497801300189263     Document Type: Article

References (38)

1. Perspectives in pineal functions
2. Possible effects of growth hormone on development of acute lymphoblastic leukaemia
3. Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts
4. Identification of lymphoid cell lines bearing receptors for somatostatin
5. Somatostatin receptors on human lymphocytes and leukaemia cells
6. In-111-octreotide scintigraphy in oncology
7. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas
8. In vitro autoradiographic and in vivo scintigraphic localisation of somatostatin receptors in human lymphatic tissue
9. Somatostatin receptor scintigraphy in malignant lymphoma: First results and comparison with glucose metabolism measured by positron emission tomography
10. Differentiation between residual cancer and thymic hyperplasia in malignant non Hodgkin's lymphoma with somatostatin receptor scintigraphy
11. Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: Results of a phase II North Central Cancer Treatment Group Trial
12. Prolactin and growth hormone receptors
13. Receptor-mediated mitogenic action of prolactin in a rat lymphoma cell line
14. Prolactin receptor gene expression in lymphoid cells
15. Growth hormone and prolactin are paracrine growth and differentiation factors in the haemopoietic system
16. Prolactin receptors and the immune system
17. Prolactin is an autocrine growth factor for the Jurkat human T-leukemic cell line
18. A role for growth hormone and prolactin in leukaemia and lymphoma?
19. All-trans retinoic acid in haematological malignancies, an update
20. Treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cis-retinoic acid
21. The effect of isotretinoin in six patients with cutaneous T-cell lymphoma
22. Retinoids in cutaneous T cell lymphomas
23. Interferon alpha and etretinate combination treatment of cutaneous T-cell lymphoma
24. 13-cis-retinoic acid induces cellular differentiation and durable remission in refractory cutaneous Ki-1 lymphoma
25. Retinoic acid-induced apoptosis and regression of a refractory Epstein-Barr virus-containing T cell lymphoma expressing multidrug-resistance phenotypes
26. Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese patients with Ki-1 anaplastic large cell lymphoma. Special emphasis in the tumor response to 13-cis retinoic acid
27. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: Role for transforming growth factor beta
28. Factors associated with the therapeutic efficacy of retinoic acids on malignant lymphomas
29. Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas
30. Selective effect of the proliferation of lymphoid cells
31. Selective effect of methoxyndoles on the lymphocyte proliferation and melatonin binding to activated human lymphoid cells
32. Effect of melatonin on mitotic and proliferation indices, and sister chromatid exchange in human blood lymphocytes
33. Preliminary studies on melatonin in the treatment of myelodislastic syndromes following cancer chemotherapy
34. Melatonin decreases bone marrow and lymphatic toxicity of adriamicin in mice bearing TLX5 lymphoma
35. Differential expression of functional adrenocorticotropic hormone receptors by subpopulations of lymphocytes
36. Effects of ACTH administration on bovine polymorphonuclear leukocyte function and lymphocyte blastogenesis
37. Interplay in vitro between ACTH, beta-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity
38. Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non Hodgkin's lymphomas: A randomized trial from the Lymphoma Group of Central Sweden